Old Web
English
Sign In
Acemap
>
Paper
>
Assessment of Low Dose Vigil® Engineered Autologous Tumor Cell (EATC) Immunotherapy in Patients with Advanced Solid Tumors
Assessment of Low Dose Vigil® Engineered Autologous Tumor Cell (EATC) Immunotherapy in Patients with Advanced Solid Tumors
2017
Luisa Manning
Minal A. Barve
Gladice Wallraven
Padmasini Kumar
Nicolas Taquet
Ernest Bognar
Eric Mendeloff
Jonathan C. Oh
Donald Rao
Beena O. Pappen
Neil Senzer
John J. Nemunaitis
Keywords:
Immunotherapy
Cancer research
low dose
in patient
Autologous tumor cell
Medicine
Vigil
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]